Corundum Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.26M | Buy |
10,498
+941
| +10% | +$109K | 0.42% | 51 |
|
|
2025
Q4 | $1.01M | Sell |
9,557
-187
| -2% | -$17.6K | 0.34% | 56 |
|
|
2025
Q3 | $818K | Buy |
9,744
+123
| +1% | +$10.1K | 0.34% | 59 |
|
|
2025
Q2 | $762K | Sell |
9,621
-149
| -2% | -$11.8K | 0.34% | 60 |
|
|
2025
Q1 | $877K | Sell |
9,770
-1,886
| -16% | -$176K | 0.42% | 56 |
|
|
2024
Q4 | $1.16M | Buy |
11,656
+1,002
| +9% | +$103K | 0.43% | 63 |
|
|
2024
Q3 | $1.21M | Sell |
10,654
-6,325
| -37% | -$751K | 0.55% | 43 |
|
|
2024
Q2 | $2.1M | Buy |
16,979
+6,493
| +62% | +$836K | 0.82% | 29 |
|
|
2024
Q1 | $1.38M | Buy |
10,486
+1,290
| +14% | +$159K | 0.67% | 29 |
|
|
2023
Q4 | $1M | Sell |
9,196
-2,585
| -22% | -$268K | 0.5% | 44 |
|
|
2023
Q3 | $1.21M | Sell |
11,781
-1,275
| -10% | -$137K | 0.69% | 31 |
|
|
2023
Q2 | $1.51M | Sell |
13,056
-4,748
| -27% | -$539K | 0.75% | 30 |
|
|
2023
Q1 | $1.89M | Buy |
17,804
+5,000
| +39% | +$540K | 0.9% | 25 |
|
|
2022
Q4 | $1.42M | Buy |
12,804
+4,604
| +56% | +$471K | 0.8% | 32 |
|
|
2022
Q3 | $706K | Buy |
8,200
+382
| +5% | +$34.1K | 0.44% | 59 |
|
|
2022
Q2 | $713K | Buy |
7,818
+900
| +13% | +$79.8K | 0.48% | 53 |
|
|
2022
Q1 | $568K | Buy |
6,918
+1,580
| +30% | +$125K | 0.53% | 70 |
|
|
2021
Q4 | $409K | Buy |
5,338
+660
| +14% | +$52.6K | 0.27% | 71 |
|
|
2021
Q3 | $351K | Buy |
4,678
+915
| +24% | +$69.6K | 0.26% | 72 |
|
|
2021
Q2 | $293K | Buy |
3,763
+432
| +13% | +$32.1K | 0.19% | 77 |
|
|
2021
Q1 | $245K | Buy |
3,331
+93
| +3% | +$6.86K | 0.19% | 82 |
|
|
2020
Q4 | $253K | Buy |
3,238
+362
| +13% | +$27.7K | 0.21% | 74 |
|
|
2020
Q3 | $228K | Buy |
+2,876
| New | +$225K | 0.22% | 72 |
|
|
2020
Q2 | – | Sell |
-2,940
| Closed | -$216K | – | 65 |
|
|
2020
Q1 | $216K | Sell |
2,940
-269
| -8% | -$21.1K | 0.31% | 50 |
|
|
2019
Q4 | $278K | Buy |
3,209
+124
| +4% | +$10.2K | 0.29% | 49 |
|
|
2019
Q3 | $248K | Sell |
3,085
-3
| -0.1% | -$240 | 0.29% | 50 |
|
|
2019
Q2 | $247K | Buy |
3,088
+23
| +0.8% | +$1.76K | 0.28% | 47 |
|
|
2019
Q1 | $243K | Sell |
3,065
-7,110
| -70% | -$532K | 0.28% | 45 |
|
|
2018
Q4 | $742K | Buy |
+10,175
| New | +$718K | 0.68% | 25 |
|
Other funds holding MRK
VCM
VPM
Corundum Group's MRK Position: Q1 2026 in Review
Corundum Group increased its Merck (MRK) stake by 9.8% in Q1 2026, buying an estimated $109K and bringing the position to 10,498 shares worth $1.26M. The position accounts for 0.42% of the portfolio, ranked #51.
Corundum Group first reported a position in MRK in Q4 2018 and has held it in 29 quarters since. The position peaked at $2.1M in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Corundum Group held 10,498 shares of Merck worth $1.26M as of Q1 2026.
- Corundum Group bought 941 Merck shares in Q1 2026, an estimated $109K.
- Merck made up 0.42% of Corundum Group's portfolio in Q1 2026, its #51 holding.
- Corundum Group first reported a position in Merck in Q4 2018 and has held it in 29 quarters since.
- Corundum Group's Merck position peaked at $2.1M in Q2 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Corundum Group's 13F filing for Q1 2026, filed 20 Apr 2026.